# The Effect of High-dose Remifentanil on Established Sunburn-induced Hyperalgesia in Human Volunteers (HighDose RemiSun)

> **NCT01015482** · PHASE4 · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 24 (estimated)

## Conditions studied

- Hyperalgesia

## Interventions

- **DRUG:** Remifentanil
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT01015482
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-11
- **Primary completion:** 2010-03
- **Final completion:** 2010-04
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2009-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01015482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01015482, "The Effect of High-dose Remifentanil on Established Sunburn-induced Hyperalgesia in Human Volunteers (HighDose RemiSun)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01015482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*